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Characterization of myosin heavy and light chains in cultured mesan-
gial cells. Analysis by sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis (SDS-PAGE) demonstrated that postconfluent mesangial
cells in primary culture expressed three myosin heavy chains (MHCs),
204 kD, 200 kD and 196 kD, in a manner similar to that of smooth
muscle cells. The MHCs of 204 kD and 200 kD in mesangial cells
reacted positively with antibodies raised against bovine aorta smooth
muscle myosin while the 196 kD MHC reacted positively with antibod-
ies against platelet myosin. Moreover, the combined content of the
MHCs in cultured mesangial cells was remarkably similar in amount to
that in cultured aortic smooth muscle cells. After three passages,
cultured mesangial cells expressed only the 196 kD MHC as has been
reported for cultured smooth muscle cells. Two phosphorylated pro-
teins were found in the immunoprecipitate after incubation of the cell
extract with antibodies against platelet myosin: a MHC of approxi-
mately 200 kD and myosin light chain (MLC) of 20 kD. The level of
MLC phosphorylation was quantitated by scanning densitometry of
autoradiograms. Arginine vasopressin (AVP) at 100 n induced MLC
phosphorylation with a maximum effect at 10 minutes. AVP enhanced
MLC phosphorylation in a dose dependent manner: maximum response
was observed with 100 nM and half maximum, at 3.5 nM. Similarly,
angiotensin 11(100 nM), endothelin-1 (10 nM) and the calcium iono-
phore, A23l87 (1 /.LM), significantly enhanced MLC phosphorylation.
Thus, although the expression of MHC was altered in quality after
mesangial cells were placed in culture, the cells remained rich in myosin
content and had an intact regulatory system for contraction which
responded to a variety of vasoconstrictive agents. These findings
support the notion that mesangial cells have contractile capability
comparable to that of smooth muscle cells.
Renal glomerular mesangial cells have been recognized as
myofibroblasts because of several features shared with vascular
smooth muscle cells and fibroblasts [1]. It has been shown
immunohistologically that, like smooth muscle cells, the mesan-
gial cells of kidneys are rich in actin and myosin [2], cytoskel-
etal elements essential for contraction [3]. Moreover, both cell
types have been shown to have receptors or specific binding
sites for, among others, angiotensin II [4—6], arginine vasopres-
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sin [4, 6, 7] and endothelin [8, 9], and to respond to these agents
with the morphological appearance of contraction [6, 10—12].
The contraction of mesangial cells is believed to regulate
GFR by modulating the glomerular capillary filtering surface
area [13]. In such pathophysiological settings as acute renal
failure, mesangial cells often become a target of insults and may
attentuate glomerular filtration rate through their contraction.
The availability of mesangial cells in culture has allowed
investigation of the effects of a variety of vasoactive agents. It
has also been shown but not explained why, after multiple
passages, cultured mesangial cells show attenuated responses in
terms of a morphological contractile response to vasoactive
agents [12].
Myosin is an essential cytoskeletal element for a variety of
cells and plays a key role in motility. A myosin molecule
consists of a pair of heavy chains (MHCs) with a molecular size
of approximately 200 kD and two pairs of light chains (MLC),
one pair at 20 kD which can be phosphorylated and the other at
17 kD [14]. The phosphorylatable MLC in non-sarcomeric cells
(that is, smooth muscle and non-muscle cells) plays a regulatory
role in that its phosphorylation promotes both actin-activated
MgATPase activity in myosin and assembly of myosin mono-
mers into filaments, leading to cell motility or contraction [3,
14]. Of note, in non-sarcomeric cells several isoforms exist for
each of the MHCs [15, 16], the 20 kD [17—19] and 17 kD MLC
[20]. Non-muscle cells contain, predominantly, small amounts
of non-muscle type myosin [21], whereas smooth muscle cells
in intact tissues are rich in myosin (approximately ten times as
much as a fibroblast) [22], which consists of smooth muscle
specific myosin heavy and light chains [17]. Recently, it has
been demonstrated that smooth muscle cells in culture alter
their MHC expression from a smooth muscle isoform to a
non-muscle isoform [15, 16]. Although unknown, alteration of
MHC expression may also occur in cultured mesangial cells and
account for the attenuated mesangial cell contraction seen after
multiple passages.
In the present paper, we examined the quality and quantity of
myosin heavy chains contained in cultured rat mesangial cells
and compared the results with those of cultured aortic smooth
muscle cells. We also determined whether cultured mesangial
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cells contained an intact regulatory system for contraction
which could respond to a variety of vasoactive agents.
Methods
Materials
Materials were obtained from the following sources: Sprague-
Dawley rats (Harlan Sprague Dawley Inc., Indianapolis, Indi-
ana, USA); sieves (Fisher Scientific Co., Pittsburgh, Pennsyl-
vania, USA); culture dishes (Nunc, InterLab, Thousand Oaks,
California, USA); RPMI 1640 medium, M-l99 medium, Hanks'
balanced salt solution (HBSS), 0.25% trypsin with 1 mM EDTA,
penicillin and streptomycin (GIBCO, Grand Island, New York);
fetal bovine serum (FBS) (HyClone, Logan, Utah, USA);
HEPES (Research Organics, Cleveland, Ohio, USA); collage-
nase (type CLS II, Worthington Biochemical Corp., Freehold,
New Jersey, USA); rhodamine phalloidin (Molecular Probes,
Eugene, Oregon, USA); sodium dodecyl sulfate (SDS), bro-
mophenol blue, Tris, 2$-mercaptoethanol and acrylamide (Bio-
Rad Laboratories, Richmond, California, USA); 3-amino-9-
ethyl-carbazole and hydrogen peroxide (Nacalai Tesque Inc.,
Kyoto, Japan); standardized Staphylococcus aureus (Pan-
sorbin; Calbiochem, La Jolla, California, USA); polyvinylidene
difluoride microporous membrane (Immobilon PVDF; Millipore
Corp., Bedford, Massachusetts, USA); endothelin-l (Peptide
Institute, Osaka, Japan); carrier-free [32P1 orthophosphate (Du-
pont Co., Wilmington, Delaware, USA); A23187, arginine
vasopressin, angiotensin II, elastase, chicken gizzard myosin,
and Amido Black lOB (Sigma, St. Louis, Missouri, USA);
peroxidase-labeled anti-rabbit IgG (Cappel Research Products,
Durham, North Carolina, USA). Anti-bovine aortic smooth
muscle myosin antiserum & anti-human platelet myosin antise-
rum were gifts from Dr. Chris Kelley of National Institutes of
Health, Bethesda, Maryland, USA.
Rat glomerular mesangial cells
Glomerular mesangial cells were isolated from rat kidneys by
a modification of a procedure described by Harper et at [231.
Kidneys were excised from male Sprague-Dawley rats weighing
100 to 120 g. Cortical tissue was minced and passed through a
series of stainless steel sieves of decreasing pore sizes: 180, 106,
and 75 m. The fraction accumulating on the 75 m sieve was
collected in Hanks balanced salt solution buffered with 20 mM
HEPES, pH 7.4, (buffered HBSS) and allowed to sediment by
gravity. The sedimentation step was repeated with buffered
HBSS three times. The glomeruli were shown to be stripped of
their capsules and virtually free of tubule tissue microscopi-
cally. Glomeruli were treated with 1 mg/mI collagenase for 15 to
20 minutes and then plated onto 100-mm plastic tissue culture
dishes in RPMI-1640 medium containing 20% FBS, 100 U/mI
penicillin, 100 j.tg/ml streptomycin. Plates were incubated in a
humidified atmosphere at 37°C in 5% CO2 in air. Mesangial cells
usually reached confluency in 10 to 14 days and the cells were
harvested by trypsinization and subcultured.
Rat smooth muscle cells
Rat thoracic aortic smooth muscle cells were isolated and
cultured by a modification of the method described by Owens et
al [24]. The descending thoracic aorta was isolated aseptically
from male Sprague-Dawley rats, weighing 200 to 225 g. The
vessels were cleaned free of fat and connective tissues and
opened longitudinally. The cleaned aorta was preincubated for
15 to 25 minutes at 37°C in a 5% CO2 and 95% air atmosphere
in HBSS containing I mg/ml collagenase, and 0.25 mg/mI
elastase with 100 U/mI penicillin and 100 .tgIml streptomycin.
The adventitia was carefully removed under a dissecting micro-
scope, and the luminal surface scraped with forceps to remove
endothelial cells. The aorta strip was then minced and incu-
bated in a fresh collagenase and elastase solution for an
additional 90 minutes with tituration at 30 minute intervals. The
dissociated cells were separated from undigested tissue by
filtration through a 75 m stainless steel sieve. FBS was added
to the filtrate to a final concentration of 20%. Cells were
collected by centrifugation at 180 g for five minutes and
resuspended in Medium 199 containing 10% FBS. Cells were
plated in 100 mm culture dishes at a density of 2 to 5 X l0
cells/cm2 and cultured in a humidified atmosphere.
Characterization of cells
Mesangial cells and smooth muscle cells were identified by
their characteristic morphological features, that is, a stellate or
spindle shape, respectively, and the presence of numerous
filament bundles in the cytoplasm as observed by phase con-
trast microscopy. The characteristic distribution of actin, which
is abundant and runs throughout the cytoplasm, was revealed
by staining with rhodamine phalloidin following the method of
MacKay et al [251. Briefly, 10,000 to 20,000 cells were plated in
8-well Lab Tek chamber slides in RPMI 1640 media supple-
mented with FBS and cultured overnight. Slides were washed
once with phosphate buffered saline (PBS), fixed at 37°C for 15
minutes with 2% paraformaldehyde in PBS, and permeabilized
with 0.1% Triton X-100 in PBS. Cells were incubated with
normal goat serum, followed by rhodamine phalloidin. Cells
were washed, mounted and observed.
Preparation of tissue and cell extracts
The rat thoracic aorta was obtained as described above. The
thoracic aortic smooth muscle cells and mesangial cells in
culture were harvested by trypsinization. After washing with
HBSS, rat thoracic aortic tissue, thoracic aortic smooth muscle
cells and mesangial cells were resuspended in extraction buffer
(40 ms'i MOPS-NaOH buffer containing 0.25 M sucrose, 0.6 M
NaC1, 1 mrvi EDTA, 2 mM EGTA, 1 mM phenylmethanesulfonyl
fluoride, 10 g/ml leupeptin, and 10 g/ml soybean trypsin
inhibitor) and homogenized [16]. Protein concentration of the
cell extracts was measured by the method of Lowry [261. The
suspension was centrifuged at 105,000 g for 30 minutes and the
supernatant was used for MHC study.
Immunoprecipitation
The soluble fraction recovered from ultracentrifugation was
incubated with anti-myosin antibody at 4°C for 90 minutes.
After an additional incubation with Pansorbin for 45 minutes,
the mixture was sedimented with a microcentrifuge for five
minutes. The pellet was washed and dissolved in SDS sample
buffer consisting of 2% SDS (wt/vol), 10% glycerol, 0.001%
bromophenol blue, 62.5 mrt Tris, pH 6.8, and 5% 2f3-mercap-
toethanol.
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SDS-polyacrylamide gel electrophoresis and immunoblotting
Gel electrophoretic analysis for myosin heavy chain (MHC)
was performed in 5% polyacrylamide gel with 0.065%
bisacrylamide using the method of Kawamoto and Adelstein
[16]. Myosin content was measured by scanning the gel stained
with Coomasie Blue using a videodensitometer (Model 620,
Bio-Rad Laboratories). Purified myosin was used as the stan-
dard.
After gel electrophoresis, proteins were transferred electri-
cally to polyvinylidene difluoride microporous membrane (Im-
mobilon PVDF) in the buffer of 25 mri Tris and 192 m'vi glycine,
pH 8.3, at 6 to 8 volts for two hours with constant stirring at 5°C
[16]. After blocking unoccupied sites by incubation in 20 mM
Tris buffer, pH 7.4, (TBS buffer) with 5% BSA for one hour at
37°C, the paper was incubated for two to six hours with rabbit
antibodies raised against bovine aortic myosin or human plate-
let myosin. The paper was, then, incubated with peroxidase-
labeled antibodies against rabbit IgG for one hour. The first and
second antisera were diluted in TBS containing 1% BSA and
0.05% Tween 20. After each incubation with antiserum, the
paper was washed with TBS containing 0.1% BSA. 3-amino-9-
ethyl-carbazole and hydrogen peroxide were used as substrates
for peroxidase color development.
Quantitation of myosin light chain phosphorylation
Phosphorylation of MLC was quantitated by a modification
of a method described by Anderson, Gimbrone and Alexander
[27]. Confluent mesangial cells in 33 mm dishes were washed
and incubated at 37°C for three hours in I ml of an isotonic
solution consisting of 130 mrvj NaC1, 4.7 m KC1, 1.2 mM
MgCI2, 1.6 mrvt CaCI2, 5 mrvi dextrose, 20mM HEPES, pH 7.4,
with the addition of 50 to 200 Ci/ml of neutralized, carrier-free
[32P] orthophosphate. After incubation, 10 d of a test agent or
vehicle in incubation buffer was added and incubated at 37°C.
The reaction was terminated by removing the incubation solu-
tion and immediately freezing the cells in ethanol at —70°C.
Cells were then thawed on ice in an extraction buffer containing
25 mrvi Tris-HC1, pH 8.8, 100 m sodium pyrophosphate, 100
mM NaF, 250 mM NaCI, 10 mrvt EGTA, 5 mrvt EDTA, 1 mM
phenylmethanesulfonyl fluoride and 50 Lg/m1 leupeptin [28].
After vortexing vigorously, the cell extract was centrifuged at
105,000 g for 30 minutes. The supernatant was incubated with
anti-myosin antibody as described above. The immunoprecipi-
tated myosin was dissolved in SDS sample buffer and subjected
to SDS-PAGE in a 12% acrylamide gel with 0.32% bisacryla-
mide using the discontinuous buffer system of Laemmli [291.
After electrophoresis, gels were stained, vacuum dried and
exposed to Kodak XR-5 X-ray film. The phosphorylated MLCs
were localized by autoradiography. The autoradiograms were
scanned and quantitated by videodensitometry. The immuno-
precipitated myosin was dissolved in SDS sample buffer and
applied in SDS 12% acrylamide gel electrophoresis. Phosphor-
ylated MLC was identified on an autoradiogram and its density
measured densitometrically.
Statistical analysis
Comparisons were made statistically using one-way ANOVA
and Bonferroni analyses.
Fig. 1. SDS polyacrylamide gel electrophoresis demonstrating myosin
heavy chain (MHC) isoforms in extracts from intact aorta, primary
cultures of aortic smooth muscle cells and cultured renal mesangial
cells at various passages. Cytosol proteins were extracted as described
in the Methods section. Each cell extract at the same protein concen-
tration (25 g) was added on a 5% acrylamide gel. The resulting gel was
stained with 0.1% Coomasie Brilliant Blue. As reported by others [15,
161, rat thoracic aortic extract contained two distinct smooth muscle
MHC isoforms of 204 kD and 200 kD (lane I), and postconfluent
primary culture of rat thoracic aortic smooth muscle cells expressed a
204 kD MHC isoform and another MHC isoform at 196 kD, a "non-
muscle" isoform (lane 2). As shown in lane 3, mesangial cells in
postconfluent primary cultures contained putative MHCs which had
identical mobilities to the 204 kD and 196 kD MHC isoforms in cultured
smooth muscle cells and in almost the same amount. Mesangial cells in
postconfluent cultures at passages 3 and 10 contained only the 196 kD
putative MHC (lanes 4 and 5, respectively).
Results
First, we determined if MHC isoforms in cultured mesangial
cells are identical to those in cultured smooth muscle cells and
if mesangial cells, like smooth muscle cells, change their MHC
expression after repeated subculturing. Soluble cell extracts
from aortic smooth muscle cells and mesangial cells at the same
protein concentration (25 g) were characterized on a SDS-5%
acrylamide gel (Fig. 1). Rat aortic smooth muscle tissue con-
tained two proteins with molecular weights of 204 kD and 200
kD (lane 1), which had been identified earlier as "smooth
muscle-' 'specific MHC isoforms [16]. Smooth muscle cells in
postconfluent primary culture expressed the 204 kD isoform
and another protein at 196 kD, the latter reported to be a
"non-muscle" isoform [16]. The 200 kD was undetectable by
Coomasie Brilliant Blue staining (lane 2). Rat glomerular
mesangial cells in postconfluent primary culture contained
putative MHCs (lane 3) whose mobilities were identical to the
204 kD and 196 kD MHC isoforms of smooth muscle cells.
Postconfluent mesangial cells at passages 3 and 10 lost expres-
sion of the 204 kD protein and expressed only the 196 kD
protein (lanes 4 and 5, respectively). These putative MHCs in
204 kD
200 kD—
196 kD
CBB ASM AFM
Con A-Myo Con A-Myo
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Table 1. Content of myosin heavy chain (MHC) in cell extracts from
rat aorta, aortic smooth muscle cell cultures and mesangial
cell cultures
Cells
MHC content
pg/rng protein
Aortic tissue 78.7 10.2
Aortic smooth muscle cell primary cultures 45.9 2.4
Glomerular mesangial cell primary cultures 35,5 2.0
Fig. 2. immunoblotting in primary cultures of glomerular mesangial
cells. Soluble extracts from mesangial cells of postconfluent primary
cultures were subjected to SDS-polyacrylamide gel electrophoresis on a
5% acrylamide gel and then transferred electrically to Immobilon paper.
Blotted proteins were stained with Amido Black lOB (lane I) or
immunostained. Blotted paper was incubated with antibodies against
bovine aortic smooth muscle or human platelet myosin (lanes 2 and 3,
respectively). After washing, the paper was incubated with peroxidase
labeled anti-rabbit IgG. The paper was washed again and incubated with
substrates for the color reaction. Although the 204 kD and 200 kD
proteins were not clearly stained by the Amido Black lOB, they became
obvious by immunostaining with anti-smooth muscle myosin antibodies
(lane 2). Anti-platelet myosin antibodies reacted with the 196 kD
putative MHC (lane 3).
postconfluent primary mesangial cell culture were examined for
their immunoreactivity to antibodies raised against bovine
aortic smooth muscle myosin and human platelet myosin.
Immunostaining with an antibody against bovine aortic smooth
muscle myosin revealed quite distinctly the presence of the 204
kD and 200 kD proteins (Fig. 2, lane 2), identifying these
proteins to be smooth muscle-specific MHCs, although these
proteins did not stain intensely on the Immobilon with Amido
Black LOB (lane 1). The protein at 196 kD reacted with an
anti-platelet myosin antibody (lane 3), revealing it to be a
non-muscle specific MHC. Cultured mesangial cells at several
different passages expressed essentially identical levels of total
MHCs (Fig. 1, lanes 3 to 5). When MHC content was quanti-
tated by scanning Coomasie Brilliant Blue-stained gels, aortic
smooth muscle cells in primary culture were found to contain
almost 60% of the total MHCs of aortic tissue (45.9 2.4 vs.
78.7 10.2 tg/mg protein, respectively; mean SE, N = 3).
Mesangial cells in primary culture contained MHCs comparable
in amount to that of smooth muscle cells (35.5 2.0 xg/mg
protein; Table 1). The ratio of the 204 kD MHC to that of the
196 kD MHC was approximately 1:6 in both smooth muscle
cells and mesangial cells in postconfluent primary culture.
We also examined the immunoprecipitability of non-muscle
myosin in cultured mesangial cells. Soluble cell extracts con-
taining 0.1 jxg MHC from mesangial cells at passage 5 were
incubated sequentially with anti-platelet myosin antibody and
I I I I
Supernatant Pellet
Fig. 3. Immunoprecipitation of myosin in extracts from cultured
mesangial cells (passage 5). Myosin heavy chain (MHC) remained in
the supernatant following incubation of the extracts with control rabbit
serum and then Pansorbin (lane 1), and no MHC was found in the pellet
(lane 3). In contrast, no MHC was found in supernatant (lane 2) and all
the MHC was recovered in pellet after incubation with anti-platelet
myosin antibodies (1 mg/mI) (lane 4).
then Pansorbin. After centrifugation, the supernatant and
washed pellet were dissolved in SDS sample buffer and heated
to dissociate the antigen-antibody complex (the myosin mole-
cule also separated into MHC and MLC). SDS-PAGE analyses
demonstrated that no MHC remained in the supernatant after
centrifugation (Fig. 3, lane 2), and that all the MHC was
recovered in the pellet (lane 4). In contrast, the MHC remained
in the supernatant, and none was found in the pellet after
incubation with control serum (lanes 1 and 3, respectively).
When the myosin in cell extracts of [32P] labeled mesangial
cells was immunoprecipitated with anti-platelet myosin and the
precipitate was subjected to SDS-PAGE, two phosphorylated
bands were found on the autoradiogram: phosphorylated MHC
and MLC with molecular weights of approximately 200 kD and
20 kD, respectively (Fig. 4). These are patterns identical to
those reported by other investigators for cultured rat aortic
smooth muscle cells 29, 301. The level of phosphorylation for
the 20 kD MLC was enhanced at 10 minutes following AVP
stimulation in a dose dependent manner. In contrast, MHC
204 kD
196 kD Data are presented as mean SE, N = 3.
Fig. 4. Autoradiogram showing phosphorylated myosin heavy chain
(MHC) of approximately 200 kD and myosin light chain (MLC) of2O kD
in cultured mesangial cells. After preincubation with 132P1 orthophos-
phate, postconfluent mesangial cells (passage 5) were incubated for 10
minutes with AVP at 0.1 nM (lane 2), 1 n (lane 3), 10 nM (lane 4), 100
nM (lane 5) and 1 M (lane 6). As compared with control (lane 1), the
level of the 20 kD MLC phosphorylation was increased by AVP in a
dose dependent manner, while that of the MHC at approximately 200
kD was not.
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Fig. 6. Time course of myosin light chain (MLC) phosphorylation
following stimulation with 100 nM AVP. MLC phosphorylation was
determined in cultured mesangial cells at passages 5 to 7. Each point
and bar depicts mean and SE of three experiments. MLC phosphoryla-
tion level increased significantly at 1 minute, peaked at 10 minutes and
tended to decline by 30 minutes, but remained higher than control.
<0.05 vs. control.
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Fig. 5. Dose response curve of myosin light chain (MLC) phosphory-
lation induced by A VP. MLC phosphorylation level was quantitated by
scanning densitometry of autoradiograms. Each point and bar repre-
sents the mean and SE of three experiments. Maximum response to
AVP was obtained at 100 nM with half maximum response at 3.5 nM.
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phosphorylation level was not affected by AVP at doses be-
tween 0.1 flM and 1 /.LM. When the level of MLC phosphoryla-
tion was quantitated, maximal effects were attained at 100 flM
with a half maximal at 3.5 nM (Fig, 5).
A time dependency of 20 kD MLC phosphorylation following
100 flM AVP stimulation was also observed (Fig. 6). A signifi-
cant increase in the phosphorylation level was observed at one
minute (172.0 10.0% of control, mean SE, N = 3, P < 0.05
vs. control), and the maximal response was attained at 10
minutes (212.3 23.8% of control). The level tended to decline
steadily, yet remained above the control level at 30 minutes (179
29.3% of control).
Responses to other vasoactive agents were examined and the
results are listed in Table 2. Each of the agents tested, 1 tM
A23187, 100 nM AG II and 10 flM endothelin-l, enhanced MLC
phosphorylation significantly at 10 minutes (P < 0.05 vs.
control): 191.5 5.0, 193.5 33.5, 254.7 30.1% of control
(mean SE, N = 3), respectively.
Discussion
In mesangial cells, filaments have been demonstrated immu-
nohistologically which react with anti-smooth muscle myosin
anti-serum [2, 311 and not with specific antibodies raised against
5 10 30
Time after stimulation, minutes
human platelet myosin [32]. Thus, it seems that mesangial cells
in situ contain predominantly smooth muscle myosin. Recent
availability of homogeneous cultures of smooth muscle and
mesangial cells prompted investigations on the effects of vaso-
active agents on contraction of these cells. It has also been
shown mat smooth muscle cells change phenotype when they
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Table 2. Phosphorylation of myosin light chain (MLC) in response to
various vasoconstrictive agents
Agents
MLC phosphorylation
% of control
A23187 (1 psi) 191.5 5.0
Angiotensin II 193.5 33.5
Endothelin 254.7 30.1
Data are presented as mean SE, N = 3, P < 0.05 vs. control.
are placed in culture [33]. The amount of smooth muscle-
specific MHCs decreases and a non-muscle type of MHC
dominates as the cells are subcultured repeatedly [15, 161; yet
smooth muscle cells in culture still contain a larger amount of
myosin, predominantly non-muscle type myosin, than non-
muscle cells [22, 34]. We have demonstrated for the first time
that rat glomerular mesangial cells in primary culture contain
204 kD and 200 kD MHCs which react with an anti-smooth
muscle myosin antibody and a 196 kD MHC which reacts with
an anti-platelet myosin antibody, features identical to those of
smooth muscle cells in primary culture [161.
It has been known that mesangial cells in prolonged culture
tend to lose their contractile ability in response to vasoactive
agents. This phenotypic alteration was attributed to either a loss
of receptors for vasoconstrictive agonists [35] or contractile
proteins [33], or tight attachment to substratum [12]. Since
non-muscle myosin had been shown to have an attenuated
contractile character compared to smooth muscle myosin [36],
alteration of myosin expression in cultured mesangial cells after
multiple passages may contribute to the reduction in contrac-
tility noted in cultured cells. In addition to the change in myosin
expression, cultured smooth muscle cells were shown in our
study to have altered amounts. The cultured rat aortic smooth
muscle cells contained 60% of the myosin found in fresh aortic
tissue, which is similar to that found in bovine tracheal smooth
muscle cells [22]. It was also demonstrated, for the first time,
that the amount of MHC in cultured mesangial cells was as large
as in cultured smooth muscle cells. The rich content of myosin
and myosin isoform expression identical to smooth muscle cells
suggest that mesangial cells have essentially identical contrac-
tile capability as smooth muscle cells.
Immunoprecipitated myosin contained two phosphorylated
proteins, a MHC of approximately 200 kD and a MLC of 20 kD,
a finding identical to smooth muscle cells [29, 30]. The degree of
MLC phosphorylation has been shown to correlate closely with
tension development or shortening velocity in smooth muscle
cells [14]. Other investigators successfully quantitated MLC
phosphorylation in smooth muscle cells using immunoprecipi-
tation with anti-smooth muscle myosin antibodies [28]. We
demonstrated here that cultured mesangial cells contain pre-
dominantly non-muscle type MHC, especially after passage 3,
and that anti-human platelet myosin antibody completely im-
munoprecipitated the myosin in the cells. Using these tech-
niques we have been successful in quantitating the MLC
phosphorylation in cultured mesangial cells between passages 3
and 10.
AVP induced MLC phosphorylation in cultured mesangial
cells in both a time- and dose-dependent manner. Our results
are in concert with the electron microscopic observations of
Ausiello et al [6], who showed morphologically that mesangial
cells respond within two minutes of the vasoconstrictor stimu-
lation and return to their original morphology by 15 minutes.
This is a somewhat shorter period of sustained contraction than
that observed in our study with MLC phosphorylation and may
be attributed to the use of calcium free medium to preincubate
the mesangial cells. In support of this, Singhal et al [37]
observed that most of the mesangial cells maintained a morpho-
logical appearance of contraction for 20 minutes after stimula-
tion (0.5 p.M AG II) in an incubation media containing 2 mt
calcium.
The dose response curve for AVP induced-mesangial cell
contraction in our study was very similar to that found in
morphological studies for vascular smooth muscle [4] and
essentially identical to that for AVP-induced enhancement of
intracellular calcium levels in cultured mesangial cells, with a
half maximal effect dose of 1.5 n [38]. MLC phosphorylation
was enhanced by other well established vasoactive agents such
as angiotensin II, endothelin and A23 187. The MLC phosphor-
ylation showed essentially identical dose response curves as
those reported for changes in intracellular calcium levels and
morphological expression of contraction.
In conclusion, myosin expression is altered as a result of
culturing mesangial cells; however, the contractile mechanism
of mesangial cells is largely conserved such that the response to
various vasoactive agents in the form of MLC phosphorylation
parallels that of changes in intracellular calcium levels and
morphological expression of contraction, as is the case for
cultured smooth muscle cells [10]. These results also indicate
that mesangial cells in situ may have essentially identical
expression of myosin, both in isoform types and amount, and
contractile capabilities identical to tissue smooth muscle cells.
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